National Institutes of Health. Cancer stat facts: prostate cancer In: Cancer.gov. 2020. https://seer.cancer.gov/statfacts/html/prost.html. Accessed 22 Aug 2022.
Brawn N, et al. Stage at presentation and survival of white and black patients with prostate carcinoma. Cancer. 1993;71(8):2569–73.
Article CAS PubMed Google Scholar
Hoffman RM, et al. Racial and ethnic differences in advanced-stage prostate cancer: the prostate cancer outcomes study. JNCI: J Nat Cancer Inst. 2001;93(5):388–95.
Article CAS PubMed Google Scholar
Centers for Disease Control and Prevention. Social determinants of health at CDC. In: CDC official website. 2022. https://www.cdc.gov/about/sdoh/index.html. Accessed 8 Dec 2022.
• Kensler KH, et al. Racial and ethnic variation in PSA testing and prostate cancer incidence following the 2012 USPSTF recommendation. J Natl Cancer Inst. 2021;113(6):719–26. This paper highlights the disparities in prostate cancer screening following the update to the 2012 recommendation.
US Preventive Services Task Force. Prostate cancer: screening. In: USPSTF official website. 2018. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening. Accessed 22 Aug 2022.
Kim SP, et al. Contemporary national trends of prostate cancer screening among privately insured men in the United States. Urology. 2016;97:111–7.
El Khoury CJ, Ros R. A systematic review for health disparities and inequities in multiparametric magnetic resonance imaging for prostate cancer diagnosis. Acad Radiol. 2021;28(7):953–62.
Washington C, Deville C Jr. Health disparities and inequities in the utilization of diagnostic imaging for prostate cancer. Abdom Radiol (NY). 2020;45(12):4090–6.
Gross MD, et al. Variation in magnetic resonance imaging-ultrasound fusion targeted biopsy outcomes in Asian American men: a multicenter study. J Urol. 2020;203(3):530–6.
Falagario UG, et al. Staging accuracy of multiparametric magnetic resonance imaging in Caucasian and African American men undergoing radical prostatectomy. J Urol. 2020;204(1):82–90.
Siegel RL, et al. Cancer statistics 2023. CA: A Cancer J Clin. 2023;73(1):17–48.
Awasthi S, et al. Genomic testing in localized prostate cancer can identify subsets of African Americans with aggressive disease. J Natl Cancer Inst. 2022;114(12):1656–64.
Article PubMed PubMed Central Google Scholar
Basourakos SP, et al. Harm-to-benefit of three decades of prostate cancer screening in Black men. NEJM Evidence. 2022;1(6):EVIDoa2200031.
Holmes JA, et al. Impact of distance to a urologist on early diagnosis of prostate cancer among Black and White patients. J Urol. 2012;187(3):883–8.
Steenland K, et al. Prostate cancer incidence and survival in relation to education (United States). Cancer Causes Control. 2004;15(9):939–45.
Rapiti E, et al. Impact of socioeconomic status on prostate cancer diagnosis, treatment, and prognosis. Cancer. 2009;115(23):5556–65.
• Barocas DA, et al. Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial. Cancer. 2013;119(12):2223–9. This comprehensive study concluded that Black men had less odds of undergoing a repeat PSA test or prostate biopsy, potentially due to limitations in access to care.
Roetzheim RG, et al. Effects of health insurance and race on early detection of cancer. JNCI: J Natl Cancer Inst. 1999;91(16):1409–15.
Article CAS PubMed Google Scholar
Ulyte A, et al. Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines. PLoS ONE. 2020;15(4):e0231409.
Article CAS PubMed PubMed Central Google Scholar
Bang KM, et al. Evaluation of recent trends in cancer mortality and incidence among blacks. Cancer. 1988;61(6):1255–61.
Article CAS PubMed Google Scholar
Austin JP, et al. Diminished survival of young blacks with adenocarcinoma of the prostate. Am J Clin Oncol. 1990;13(6):465–9.
Article CAS PubMed Google Scholar
Austin JP, Convery K. Age-race interaction in prostatic adenocarcinoma treated with external beam irradiation. Am J Clin Oncol. 1993;16(2):140–5.
Article CAS PubMed Google Scholar
Aziz H, et al. Radiation-treated carcinoma of prostate. Comparison of survival of black and white patients by Gleason’s grading system. Am J Clin Oncol. 1988;11(2):166–71.
Article CAS PubMed Google Scholar
Bernard B, et al. Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer. Cancer. 2017;123(9):1536–44.
Article CAS PubMed Google Scholar
McKay RR, et al. Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration. Cancer. 2021;127(3):403–11.
Article CAS PubMed Google Scholar
•• Stokes WA, et al. Racial differences in time from prostate cancer diagnosis to treatment initiation. Cancer. 2013;119(13):2486–93. This paper used a veteran study cohort with equal-access and showed that although equal-access may partially address institutional inequalities, some overall racial disparities remain.
Carson AP, et al. Trends and racial differences in the use of androgen deprivation therapy for metastatic prostate cancer. J Pain Symptom Manage. 2010;39(5):872–81.
Article CAS PubMed Google Scholar
• Beebe-Dimmer JL, et al. Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation. Cancer Medicine. 2019;8(6):3325–35. This study of elderly Medicare patients showed that Black patients are less likely to pursue aggressive treatment options.
Article PubMed PubMed Central Google Scholar
Nguyen C, et al. Racial, socioeconomic, and geographic disparities in the receipt, timing to initiation, and duration of adjuvant androgen deprivation therapy in men with prostate cancer. J Racial Ethn Health Disparities. 2019;6(1):133–42.
Moses KA, et al. Racial/ethnic disparity in treatment for prostate cancer: does cancer severity matter? Urology. 2017;99:76–83.
Gray J, et al. Temporal trends and the impact of race, insurance, and socioeconomic status in the management of localized prostate cancer. Eur Urol. 2017;71(5):729–37.
Friedlander DF, et al. Racial disparity in delivering definitive therapy for intermediate/high-risk localized prostate cancer: the impact of facility features and socioeconomic characteristics. Eur Urol. 2018;73(3):445–51.
Blendon RJ, et al. Access to medical care for Black and White Americans: a matter of continuing concern. jAMA. 1989;261(2):278–81.
Article CAS PubMed Google Scholar
Loehrer J Sr, et al. Knowledge and beliefs about cancer in a socioeconomically disadvantaged population. Cancer. 1991;68(7):1665–71.
Connell CL, et al. Barriers to healthcare seeking and provision among African American adults in the rural Mississippi delta region: community and provider perspectives. J Community Health. 2019;44(4):636–45.
Article PubMed PubMed Central Google Scholar
Washington HA. Medical apartheid : the dark history of medical experimentation on black americans from colonial times to the present. 1st ed. New York: Doubleday; 2006.
Richardson A, et al. Effects of race/ethnicity and socioeconomic status on health information-seeking, confidence, and trust. J Health Care Poor Underserved. 2012;23(4):1477–93.
• Smirnoff M, et al. A paradigm for understanding trust and mistrust in medical research: the Community VOICES study. AJOB Empir Bioeth. 2018;9(1):39–47. In this study, they interview New York City residents to understand patients' trust or mistrust in medical research.
Article CAS PubMed PubMed Central Google Scholar
Pamies RJ, Woodard LJ. Cancer in socioeconomically disadvantaged populations. Primary Care: Clin Office Pract. 1992;19(3):443–50.
Yin D, et al. Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups? Cancer Causes Control. 2010;21(10):1721–30.
Article PubMed PubMed Central Google Scholar
Cohen JH, et al. Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States). Cancer Causes Control. 2006;17(6):803–11.
Barocas DA, Penson DF. Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gap. BJU Int. 2010;106(3):322–8.
留言 (0)